title: Is there a genetic factor in flecainide toxicity?
authors.affiliation: Abteilung für Experimentelle und Klinische Pharmakologie, Bundesgesundheitsamt, Berlin, Federal Republic of Germany.
authors.forename: J
authors.initials: J
authors.lastname: Beckmann
authors.forename: R
authors.initials: R
authors.lastname: Hertrampf
authors.forename: U
authors.initials: U
authors.lastname: Gundert-Remy
authors.forename: G
authors.initials: G
authors.lastname: Mikus
authors.forename: A S
authors.initials: AS
authors.lastname: Gross
authors.forename: M
authors.initials: M
authors.lastname: Eichelbaum
mesh_terms: D005424:Flecainide / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D008657:Metabolic Clearance Rate; D010641:Phenotype; D013034:Sparteine / Q000378:metabolism
chemical_list: D013034:Sparteine; D005424:Flecainide